A disproportionality analysis (Godfrey et al., JEADV 2025) found a reporting odds ratio of 1.73 for tirzepatide (95% CI: 1.42 to 2.09), and as high as 2.46 for semaglutide
Activation of the Nrf2 pathway suppresses reactive-oxygen-species generation in podocytes, down-regulates transforming growth factor (TGF-), and limits mesangial matrix expansion
PlexusDx patients using compounded semaglutide achieve consistent weekly dosing regardless of which approved site they choose, as long as injection technique remains correct
Semaglutide can improve insulin sensitivity and blood sugar control, which may allow some men to reduce or discontinue diabetes medicationsa change that requires medical supervision
Blue Cross Blue Shield does cover ABA therapy in Missouri under most plans
Researchers conclude low dose lithium replacement with amyloid-evading salts is a potential approach to the prevention and treatment of AD [29]